Sources and updates, May 8
Sources and updates for the week of May 8 include booster shots, vaccine attitudes, wastewater data, and source diversity.
Read MoreSources and updates for the week of May 8 include booster shots, vaccine attitudes, wastewater data, and source diversity.
Read MoreLast fall, I wrote that the U.S. did not have the data we needed to make informed decisions about booster shots. Several months later, we still don’t have the data we need, as questions about a potential BA.2 wave and other future variants abound. Discussions at a recent FDA advisory committee meeting made these data gaps clear.
Read MoreSources and updates for the week of March 13 include vaccine data annotations, free rapid tests, a combination of Delta and Omicron, and more.
Read MoreWhat has the U.S. learned from the last two years, and what lessons can we take forward for future COVID-19 surges and other infectious disease outbreaks? The Biden administration has released a new pandemic preparedness plan that addresses these questions.
Read MoreAs more states and other institutions lift COVID-19 safety measures, the shift has sparked a conversation about who remains most vulnerable to COVID-19 during this period. These vulnerable groups include unvaccinated and unboosted seniors, immunocompromised people, and pregnant people.
Read MoreOmicron updates for the week of February 13 include BA.2 estimates, vaccine effectiveness from a booster shot, COVID-19 in deer, and more.
Read MoreOmicron updates this week include BA.2’s transmissibility, the importance of vaccination to protect against severe symptoms, and the U.S.’s high death toll.
Read MoreIn January, COVAX set a goal that many global health advocates considered modest: delivering 2.3 billion vaccine doses to low- and middle-income countries by the end of 2021. is saying it’ll deliver just 800 million vaccine doses by the end of 2021, according to the Washington Post, and only about 600 million had been delivered by early December.
Read MoreIt’s been about a month since the FDA and CDC authorized a version of Pfizer’s vaccine for children ages five to 11. Those kids whose parents immediately took them to get vaccinated are now eligible for their second doses, and will be considered fully vaccinated by Christmas. Despite widespread availability of the shots, vaccine uptake has varied wildly.
Read MoreWe continue to learn more about this new variant as it spreads rapidly across the world, though much of the data are still preliminary. Here are a few major updates, including how vaccines fare against Omicron, its rapid spread, and more.
Read More